SimpliFed
Seed Round in 2025
SimpliFed is a telehealth company that offers virtual breastfeeding support and broader maternal care services to new and pregnant parents. Founded in 2020, it addresses challenges such as sleep deprivation, uncertainty, and complex infant nutrition questions. The company builds trusted relationships with parents and partners with healthcare payers and providers to deliver a comprehensive maternal health operating system covering pregnancy, postpartum, and baby feeding.
Rochester Technology and Manufacturing Association
Grant in 2024
The Rochester Technology and Manufacturing Association (RTMA) fosters manufacturing innovation and growth. By collaborating with businesses, academia, and government, RTMA helps the local manufacturing community.
Daystar Kids
Grant in 2024
Daystar Kids is a nonprofit organization that provides therapeutic, educational enrichment, and family support services.
RochesterWorks
Grant in 2024
RochesterWorks is Monroe County's largest employment and training initiative, focused on developing a robust workforce in the Rochester, NY region. It offers a range of free services to job seekers, youth, and businesses through its two full-service Career Centers located on North Goodman Street and Waring Road. RochesterWorks assists businesses with various aspects of the employment process, including recruitment, assessment, placement, and training. Additionally, it connects businesses to federally-funded employment and training programs, providing valuable support that helps to streamline hiring processes and reduce costs. By fostering collaboration between job seekers and employers, RochesterWorks plays a crucial role in enhancing the local labor market.
FuzeHub is a not-for-profit organization that provides assistance to small- to medium-sized manufacturing companies. They offer support in areas such as technology commercialization, workforce development, and supply chain optimization. By connecting companies with resources, expertise, and funding opportunities, FuzeHub aims to help these businesses grow and thrive in the competitive manufacturing industry. Through their network of industry experts and partnerships, FuzeHub serves as a valuable resource for manufacturers looking to innovate, improve productivity, and stay ahead of market trends.
Envisagenics
Series B in 2024
Envisagenics is a Huntington, New York-based company that develops a predictive analytics and bioinformatics platform to accelerate RNA therapeutics discovery. The cloud-based SpliceCore platform analyzes RNA sequencing data with artificial intelligence to identify splicing errors linked to disease, predict drug targets, and guide the design of RNA-based therapies. By translating transcriptomic insights into actionable targets, Envisagenics aims to reduce the time, cost, and risk of pharmaceutical development and to support partnerships with biopharma organizations. The firm focuses on uncovering RNA splicing alterations and translating them into therapeutic candidates, enabling researchers to validate targets and biomarkers more efficiently. The company originated as a spinout from Cold Spring Harbor Laboratory and emphasizes the use of AI and machine learning to simplify complex biomedical data for therapeutic discovery.
FIFCO renders brewing, packaging, importing, marketing and selling services.
WISE Women’s Business Center
Grant in 2024
WISE Women’s Business Center provide comprehensive business training and counseling.
Dimensional Energy
Series A in 2023
Dimensional Energy is a chemistry company specializing in artificial photosynthesis. It aims to produce eco-friendly polymers and chemical intermediaries by efficiently harnessing sunlight using scalable reactors and innovative catalysts.
Mohawk Valley EDGE
Grant in 2023
Mohawk Valley EDGE is a nonprofit economic development organization based in Rome, New York. It coordinates a comprehensive program to help businesses grow and supports public-private efforts to strengthen opportunities and attract new industries to Oneida County. The organization collaborates with local stakeholders to foster investment, job creation, and regional competitiveness. Its assets are overseen by a board.
Stark Truss Company
Grant in 2023
Stark Truss Company is a building materials company that manufactures roof and floor trusses.
WCNY is Central New York’s public broadcasting company, providing great local and national programming, high-quality educational television.
Deerfield Management
Grant in 2023
Deerfield Management is a New York-based investment firm established in 1994 that focuses on healthcare. It operates across investment, information, and philanthropy to support the healthcare ecosystem. The firm provides private and public investments and offers long-term, structured capital to both public and private healthcare companies. Its portfolio spans life sciences, medical devices, diagnostics, digital health, and health services. As an investment adviser, it seeks opportunities in healthcare products and services and aims to accelerate innovation by combining capital with industry insight.
Applied DNA Sciences
Grant in 2023
Applied DNA Sciences specializes in developing and implementing DNA-based technology solutions for various applications. These include supply chain security and product authentication using SigNature molecular tags, portable DNA readers, and a CertainT Supply Chain Platform. Additionally, they offer COVID-19 diagnostic testing services under the LineaTM trademark and non-diagnostic pooled surveillance testing under safeCircle. The company also provides preclinical contract research and manufacturing services for nucleic acid-based therapeutics.
Lidrotec specializes in developing wafer dicing laser machines for production processes. Utilizing ultrashort pulse processing technology, the company enables high-precision cutting and drilling of various materials, benefiting semiconductor industries by enhancing process speed with maximum precision.
Founded in 2016, LocalCoho is a sustainable fish company based in Auburn, NY. It specializes in responsibly raising non-GMO, certified organic salmon, known for its rich, reddish-orange meat and healthy oil content.
Magnolia NeuroSciences
Series A in 2018
Magnolia Neurosciences Corporation is a New York-based company focused on drug discovery and development, specifically targeting neuroprotective therapies for central nervous system diseases and neurodegeneration. Established in 2018, the company aims to create proprietary small molecule therapeutics that prevent neuronal cell death, offering new treatment options for patients with neurodegenerative disorders and related conditions. Magnolia Neurosciences was founded to advance technologies developed at The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery Division and the Neurodegeneration Consortium. Through its innovative approach, the company seeks to address significant medical needs in the field of neurology.
Lodo Therapeutics
Series A in 2016
Lodo Therapeutics Corporation is a drug discovery and development company dedicated to creating novel therapeutics derived from natural sources. It focuses on addressing significant health challenges, particularly resistant infectious diseases and cancers, by collaborating with global pharmaceutical companies and leading non-governmental organizations. Founded to realize the scientific vision of Dr. Sean Brady from Rockefeller University, Lodo Therapeutics utilizes a genome-based, culture-independent platform to discover and characterize small molecules sourced from environmental microbial DNA. This innovative approach leverages advancements in DNA sequencing and bioinformatics to explore the untapped potential of microbial evolution, aiming to identify therapeutically valuable pharmaceutical products. Headquartered in New York City at the Alexandria Center for Life Science, Lodo Therapeutics is committed to harnessing the power of nature in the fight against undruggable targets and high unmet medical needs.
Petra Pharma
Series A in 2016
Petra Pharma Corporation is a clinical-stage pharmaceutical company based in New York, focused on discovering and developing innovative therapies that modulate phosphoinositide (PI) signaling pathways for the treatment of cancer and metabolic diseases. Founded in 2015, the company targets novel enzyme pathways that play crucial roles in various cellular processes, such as cell division, growth, trafficking, and signaling. By developing small molecules aimed at these processes, Petra Pharma seeks to create impactful therapeutic options that enhance patient care and improve health outcomes.